IL17D: A Drug Target / Disease Biomarker (G53342)

IL17D: A Drug Target / Disease Biomarker

The Interleukin-17D (IL-17D) protein is a cytokine that plays a crucial role in the immune system and inflammation. It is a member of the IL-17 family, which includes IL-1, IL-2, IL-3, and IL-4, and is expressed in various tissues and cells throughout the body. IL-17D is a 19kDa protein that is expressed in the cytoplasm of various cell types, including macrophages, dendritic cells, and epithelial cells.

IL-17D is involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. It has been shown to play a role in the development and maintenance of various diseases, including autoimmune diseases, chronic obstructive pulmonary disease (COPD), and cancer.

One of the most promising aspects of IL-17D is its potential as a drug target. The ability of IL-17D to stimulate the production of pro-inflammatory cytokines, such as TNF-alpha and IL-8, makes it an attractive target for the development of new anti-inflammatory drugs. Additionally, the fact that IL-17D is also involved in the regulation of cellular immune responses has led to the exploration of its potential as a vaccine adjuvant.

IL-17D has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-beta pathway. This pathway is involved in the regulation of cell growth, differentiation, and inflammation, and has been implicated in the development of various diseases, including cancer. The role of IL-17D in TGF-beta signaling has led to the exploration of its potential as a new therapeutic target for cancer.

In addition to its potential as a drug target and biomarker, IL-17D has also been shown to have a role in the regulation of cellular interactions. It has been shown to play a role in the regulation of adhesion and migration of various cell types, including cancer cells. This role in cell-cell interactions has led to the exploration of its potential as a new therapeutic target for cancer.

Overall, IL-17D is a protein that has significant potential as a drug target and biomarker. Its ability to stimulate the production of pro-inflammatory cytokines, its involvement in cellular signaling pathways, and its role in cell-cell interactions make it an attractive target for the development of new therapeutic drugs. Further research is needed to fully understand the role of IL-17D in various biological processes and to explore its potential as a drug target and biomarker.

Protein Name: Interleukin 17D

Functions: Induces expression of IL6, CXCL8/IL8, and CSF2/GM-CSF from endothelial cells

The "IL17D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL17D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IL17F | IL17RA | IL17RB | IL17RC | IL17RD | IL17RE | IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4 | ILDR1 | ILDR2 | ILF2 | ILF3 | ILF3-DT | ILK | ILKAP | ILRUN | ILVBL | Imidazoline I2 receptor (I2) | Imidazoline I3 receptor (I3) | Imidazoline receptor | IMMP1L | IMMP2L | IMMT | IMMTP1 | Immunoglobulin A | Immunoglobulin E (IgE) | Immunoglobulin G | Immunoglobulin M | Immunoglobulin-Like Domain Containing Receptor | Immunoproteasome | IMP3 | IMP4 | IMPA1 | IMPA1P1